THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Clinical trials for THERAPY-RELATED ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new THERAPY-RELATED ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for THERAPY-RELATED ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tailored therapy boosts hope for older leukemia patients
Disease control CompletedThis study looked at whether matching treatment to a patient's genetic risk and overall health can improve outcomes for older adults (60+) with acute myeloid leukemia. Participants received either standard intensive or milder chemotherapy based on their personal risk profile. The…
Matched conditions: THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 17, 2026 07:26 UTC
-
New Two-Step transplant shows promise for tough blood cancers
Disease control CompletedThis study tested a two-step stem cell transplant for people with high-risk blood cancers like leukemia and lymphoma. First, patients got low-dose chemotherapy and radiation to prepare the body. Then, they received donor stem cells and immune cells to help destroy remaining cance…
Matched conditions: THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 16, 2026 12:51 UTC
-
New drug combo shows promise in Tough-to-Treat leukemia
Disease control CompletedThis early-phase study tested a combination of two drugs, pevonedistat and decitabine, in 12 adults with high-risk acute myeloid leukemia (AML). The main goal was to find the safest dose and check for side effects. Researchers also looked at whether the treatment helped shrink or…
Matched conditions: THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
Real-World study reveals how a leukemia drug performs outside the lab
Knowledge-focused CompletedThis study looked at 113 adults in Italy with certain types of acute myeloid leukemia (AML) who were treated with Vyxeos liposomal as part of their normal care. Researchers wanted to see how many patients achieved complete remission without signs of leftover disease. The goal was…
Matched conditions: THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Sponsor: Jazz Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:04 UTC